ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 453,97
0,41%
Dow Jones
42 518,28
0,52%
DAX
20 423,88
0,80%
Brent Oil
79,52
-0,23%
Bitcoin
96 648,79
0,15%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Omthera Pharmaceuticals, Inc. (MM) (OMTH) Cours

Omthera Pharmaceuticals, Inc. (MM)

Omthera Pharmaceuticals, Inc. (MM) (OMTH)

NASDAQ
13,30
0,00
(0,00%)
Fermé 15 Janvier 10:00PM
Retardé de 15 minutes
13,30
0,00
( 0,00% )
Avant marché: 1:00AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
13,30
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
13,30
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

OMTH Dernières nouvelles

Plus de nouvelles

Omthera Stockholders Approve Acquisition by AstraZeneca

Omthera Stockholders Approve Acquisition by AstraZeneca PR Newswire PRINCETON, N.J., July 16, 2013 PRINCETON, N.J., July 16, 2013 /PRNewswire/ -- The stockholders of Omthera Pharmaceuticals, Inc...

16 Juillet 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides

Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides PR Newswire PRINCETON, N.J., July 9, 2013 PRINCETON, N.J., July 9, 2013...

09 Juillet 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period

Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period PR Newswire PRINCETON, N.J., June 27, 2013 PRINCETON, N.J., June 27, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc...

27 Juin 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders

Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders PR Newswire PRINCETON, N.J., June 13, 2013 PRINCETON, N.J., June 13, 2013 /PRNewswire/...

13 Juin 2013
PR Newswire (US)

OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by Board

NEW YORK, June 4, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Omthera Pharmaceuticals, Inc. ("Omthera" or the "Company") (Nasdaq:OMTH) of claims of breaches of fiduciary duty...

04 Juin 2013
GlobeNewswire Inc.

Rigrodsky & Long, P.A. Investigates Omthera Pharmaceuticals, Inc. Buyout

AstraZeneca PLC offers $12.70 per share to Omthera Pharmaceuticals shareholders

31 Mai 2013
Business Wire

Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm

Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm PR Newswire DALLAS, May 30, 2013 DALLAS, May 30, 2013 /PRNewswire/...

31 Mai 2013
PR Newswire (US)

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Omthera Pharmaceuticals, Inc. (“Omthera” or the “Company”) (Nasdaq:...

30 Mai 2013
Business Wire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

OMTH - Frequently Asked Questions (FAQ)

What is the current OMTHERA PHARMACEUTICALS, INC. share price?
The current share price of OMTHERA PHARMACEUTICALS, INC. is US$ 13,30
What is the 1 year trading range for OMTHERA PHARMACEUTICALS, INC. share price?
OMTHERA PHARMACEUTICALS, INC. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SGBXSafe and Green Holdings Corporation
US$ 1,15
(112,96%)
37,61M
MGIHMillennium Group International Holdings Ltd
US$ 2,66
(48,60%)
3,94M
VMARVision Marine Technologies Inc
US$ 2,07
(47,86%)
8,91M
DXRDaxor Corporation
US$ 11,83
(40,33%)
11
LXEOLexeo Therapeutics Inc
US$ 8,00
(37,93%)
25
DYNXDynamix Corporation
US$ 5,01
(-48,88%)
1
NESRNational Energy Services Reunited Corporation
US$ 5,11
(-41,47%)
6
GIFTGiftify Inc
US$ 0,95
(-34,48%)
7,98k
EBMTEagle Bancorp Montana Inc
US$ 10,01
(-31,90%)
6
HTLMHomesToLife Ltd
US$ 5,20
(-31,13%)
406
SGBXSafe and Green Holdings Corporation
US$ 1,15
(112,96%)
37,61M
GCTKGlucoTrack Inc
US$ 0,0887
(-27,30%)
15,56M
HSDTHelius Medical Technologies Inc
US$ 0,8795
(27,10%)
12,16M
WINTWindtree Therapeutics Inc
US$ 0,222
(-11,16%)
12,08M
RIMEAlgorhythm Holdings Inc
US$ 0,0548
(-29,92%)
9,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
OMTH
OMTHERA PHARMACEUTICALS, INC.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés